HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Caulfield Selected Research

Vaccines

1/2012Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Caulfield Research Topics

Disease

2Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 01/2019
2Myocardial Infarction
01/2018 - 01/2017
1Inflammation (Inflammations)
01/2019
1Thrombocytopenia (Thrombopenia)
10/2013
1Anthrax
01/2012
1Growth Disorders
01/2012
1Malaria
11/2006
1Insulin Resistance
03/2002
1Type 2 Diabetes Mellitus (MODY)
03/2002
1Weight Gain
01/2002

Drug/Important Bio-Agent (IBA)

3LipidsIBA
01/2019 - 03/2002
2C-Reactive ProteinIBA
01/2019 - 03/2002
2AntibodiesIBA
10/2013 - 01/2012
2Insulin (Novolin)FDA Link
01/2012 - 03/2002
2Troglitazone (Rezulin)FDA Link
03/2002 - 01/2002
1Lipoproteins (Lipoprotein)IBA
01/2019
1Group II Phospholipases A2IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1Platelet Membrane GlycoproteinsIBA
10/2013
1Integrin alpha2IBA
10/2013
1Amiodarone (Amiodarona)FDA LinkGeneric
10/2013
1VaccinesIBA
01/2012
1Conjugate VaccinesIBA
01/2012
1Capsules (Microcapsules)IBA
01/2012
1AntigensIBA
01/2012
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2012
1Protein Subunit VaccinesIBA
11/2006
1Fibrinogen (Factor I)FDA Link
03/2002
1Glyburide (Glibenclamide)FDA LinkGeneric
03/2002
1Glucose (Dextrose)FDA LinkGeneric
03/2002
1oxidized low density lipoproteinIBA
03/2002
1Metformin (Glucophage)FDA LinkGeneric
03/2002
1Plasminogen Activator Inhibitor 1IBA
03/2002
1LeptinIBA
01/2002

Therapy/Procedure

1Secondary Prevention
01/2019
1Glycemic Control
03/2002
1Therapeutics
03/2002